A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer

被引:28
作者
Deng, Zhengdong [1 ]
Li, Xiangyu [1 ]
Shi, Yuanxin [1 ]
Lu, Yun [1 ]
Yao, Wei [2 ]
Wang, Jianming [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Canc Res Ctr Affiliated Tongji Hosp, Dept Biliary & Pancreat Surg, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Tongji Hosp, Dept Oncol, Wuhan, Peoples R China
[3] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic cancer; autophagy-related lncRNA signature; prognostic prediction; LINC01559; chemoresistance; LONG NONCODING RNAS; TRICHOSTATIN-A; GROWTH;
D O I
10.3389/fcell.2020.606817
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autophagy is an important bioprocess throughout the occurrence and development of cancer. However, the role of autophagy-related lncRNAs in pancreatic cancer (PC) remains obscure. In the study, we identified the autophagy-related lncRNAs (ARlncRNAs) and divided the PC patients from The Cancer Genome Atlas into training and validation set. Firstly, we constructed a signature in the training set by the least absolute shrinkage and selection operator penalized cox regression analysis and the multivariate cox regression analysis. Then, we validated the independent prognostic role of the risk signature in both training and validation set with survival analysis, receiver operating characteristic analysis, and Cox regression. The nomogram was established to demonstrate the predictive power of the signature. Moreover, high risk scores were significantly correlated to worse outcomes and severe clinical characteristics. The Pearson's analysis between risk scores with immune cells infiltration, tumor mutation burden, and the expression level of chemotherapy target molecules indicated that the signature could predict efficacy of immunotherapy and targeted therapy. Next, we constructed an lncRNA-miRNA-mRNA regulatory network and identified several potential small molecule drugs in the Connectivity Map (CMap). What's more, quantitative real-time PCR (qRT-PCR) analysis showed that serum LINC01559 could serve as a diagnostic biomarker. In vitro analysis showed inhibition of LINC01559 suppressed PC cell proliferation, migration, and invasion. Additionally, silencing LINC01559 suppressed gemcitabine-induced autophagy and promoted the sensitivity of PC cells to gemcitabine. In conclusion, we identified a novel ARlncRNAs signature with valuable clinical utility for reliable prognostic prediction and personalized treatment of PC patients. And inhibition of LINC01559 might be a novel strategy to overcome chemoresistance.
引用
收藏
页数:17
相关论文
共 34 条
[1]   Outcomes in Operative Management of Pancreatic Cancer [J].
Bliss, Lindsay A. ;
Witkowski, Elan R. ;
Yang, Catherine J. ;
Tseng, Jennifer F. .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (05) :592-598
[2]   The emerging role of lncRNAs in the regulation of cancer stem cells [J].
Castro-Oropeza, Rosario ;
Melendez-Zajgla, Jorge ;
Maldonado, Vilma ;
Vazquez-Santillan, Karla .
CELLULAR ONCOLOGY, 2018, 41 (06) :585-603
[3]   Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer [J].
Chan, Emily ;
Arlinghaus, Lori R. ;
Cardin, Dana B. ;
Goff, Laura ;
Berlin, Jordan D. ;
Parikh, Alexander ;
Abramson, Richard G. ;
Yankeelov, Thomas E. ;
Hiebert, Scott ;
Merchant, Nipun ;
Bhaskara, Srividya ;
Chakravarthy, Anuradha Bapsi .
RADIOTHERAPY AND ONCOLOGY, 2016, 119 (02) :312-318
[4]   New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma [J].
Chen, Binghai ;
Wang, Chengyue ;
Zhang, Jin ;
Zhou, Yang ;
Hu, Wei ;
Guo, Tao .
CANCER CELL INTERNATIONAL, 2018, 18
[5]   Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy [J].
Chen, Kuang-Den ;
Lin, Chih-Che ;
Tsai, Ming-Chao ;
Huang, Kuang-Tzu ;
Chiu, King-Wah .
BIOMEDICAL JOURNAL, 2018, 41 (03) :163-168
[6]   Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction [J].
Chen, Ping ;
Wu, Jian-Nong ;
Shu, Yang ;
Jiang, He-Guo ;
Zhao, Xiao-Hui ;
Qian, Hai ;
Chen, Kang ;
Lan, Ting ;
Chen, Chen-Guo ;
Li, Jian .
CLINICAL SCIENCE, 2018, 132 (13) :1417-1433
[7]   Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression [J].
Chen, Xiao ;
Wang, Jie ;
Xie, Fei ;
Mou, Tinggang ;
Zhong, Pingyong ;
Hua, Hao ;
Liu, Pan ;
Yang, Qin .
AGING-US, 2020, 12 (14) :14452-14466
[8]   Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers [J].
Deist, Timo M. ;
Dankers, Frank J. W. M. ;
Valdes, Gilmer ;
Wijsman, Robin ;
Hsu, I-Chow ;
Oberije, Cary ;
Lustberg, Tim ;
van Soest, Johan ;
Hoebers, Frank ;
Jochems, Arthur ;
El Naqa, Issam ;
Wee, Leonard ;
Morin, Olivier ;
Raleigh, David R. ;
Bots, Wouter ;
Kaanders, Johannes H. ;
Belderbos, Jose ;
Kwint, Margriet ;
Solberg, Timothy ;
Monshouwer, Rene ;
Bussink, Johan ;
Dekker, Andre ;
Lambin, Philippe .
MEDICAL PHYSICS, 2018, 45 (07) :3449-3459
[9]   Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells [J].
Donadelli, M ;
Costanzo, C ;
Faggioli, L ;
Scupoli, MT ;
Moore, PS ;
Bassi, C ;
Scarpa, A ;
Palmieri, M .
MOLECULAR CARCINOGENESIS, 2003, 38 (02) :59-69
[10]   Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine [J].
Donadelli, Massimo ;
Costanzo, Chiara ;
Beghelli, Stefania ;
Scupoli, Maria Teresa ;
Dandrea, Mario ;
Bonora, Antonio ;
Piacentini, Paolo ;
Budillon, Alfredo ;
Caraglia, Michele ;
Scarpa, Aldo ;
Palmieri, Marta .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (07) :1095-1106